Narcotic Analgesics

ABSTRAL (fentanyl) transmucosal immediate-release tablets by ProStrakan

Abstral transmucosal tablets approved for breakthrough cancer pain

Abstral (fentanyl transmucosal immediate-release tablets, from ProStrakan) has been approved by the FDA for the management of breakthrough pain in adult patients with cancer, ≥18 years old, who already use opioid pain medication around the clock and who need and are able to safely use high doses of an additional opioid medicine.